[1]
|
李兴艳, 杜勇军. PPARα与2型糖尿病性骨质疏松的相关性研究进展[J]. 中国骨质疏松杂志, 2018, 24(8): 1093-1096.
|
[2]
|
廖二元, 孟迅吾, 徐苓, 等. 原发性骨质疏松症诊疗指南[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-444.
|
[3]
|
赵心, 张晓梅, 纪立农. 2型糖尿病患者骨代谢改变的研究进展[J]. 中同糖尿病杂志, 2018, 26(7): 613-616.
|
[4]
|
林德民, 谢兴文, 李宁, 等. PI3K/AkT通路与骨质疏松症的关系及中医药干预的研究进展[J]. 中国骨质疏松杂志, 2021, 27(6): 922-926.
|
[5]
|
Zhang, Y., Yang, S.N., Zhang, M., et al. (2019) Glycyr-rhetinic Acid Improves Insulin-Response Pathway by Regulating the Balance between the Ras/MAPK and PI3K/Akt Pathways. Nutrients, 11, 604-613.
https://doi.org/10.3390/nu11030604
|
[6]
|
Jiang, H.T., Ran, C.C., Liao, Y.P., et al. (2019) IGF-1 Reverses the Os-teogenic Inhibitory Effect of Dexamethasone on BMP9-Induced Osteogenic Differentiation in Mouse Embryonic Fibro-blasts via PI3K/AKT/COX-2 Pathway. The Journal of Steroid Biochemistry and Molecular Biology, 191, 105363-105371.
https://doi.org/10.1016/j.jsbmb.2019.04.012
|
[7]
|
Harada, S. and Rodan, G.A. (2003) Control of Osteoblast Func-tion and Regulation of Bone Mass. Nature, 423, 349-355. https://doi.org/10.1038/nature01660
|
[8]
|
Breitbart, H., Rotman, T., Rubinstein, S., et al. (2010) Role and Regulation of PI3K in Sperm Capacitation and the Acrosome Reaction. Molecular and Cellular Endocrinology, 314, 234-238. https://doi.org/10.1016/j.mce.2009.06.009
|
[9]
|
Lupia, E., Pigozzi, L., Goffi, A., et al. (2014) Role of Phosphoinositide 3-Kinase in the Pathogenesis of Acute Pancreatitis. World Journal of Gastroenterology, 20, 15190-15199. https://doi.org/10.3748/wjg.v20.i41.15190
|
[10]
|
Xiao, W., Wang, Y., Pacios, S., Li, S. and Graves, D.T. (2016) Cellular and Molecular Aspects of Bone Remodeling. Frontiers of Oral Biology, 18, 9-16. https://doi.org/10.1159/000351895
|
[11]
|
Jabbour, E., Ottmann, O.G., Deininger, M., et al. (2014) Targeting the Phosphoinositide 3-Kinase Pathway in Hematologic Malignancies. Haematologica, 99, 7-18. https://doi.org/10.3324/haematol.2013.087171
|
[12]
|
Hers, I., Vincent, E.E. and Tavaré, J.M. (2011) Akt Signalling in Health and Disease. Cell Signaling, 23, 1515-1527.
https://doi.org/10.1016/j.cellsig.2011.05.004
|
[13]
|
Manning, B.D. and Cantley, L.C. (2007) AKT/PKB Signaling: Navigating Downstream. Cell, 129, 1261-1274.
https://doi.org/10.1016/j.cell.2007.06.009
|
[14]
|
McNamara, C.R. and Degterev, A. (2011) Small Molecule Inhibi-tors of the P13K Signaling Network. Future Medicinal Chemistry, 3, 549-565. https://doi.org/10.4155/fmc.11.12
|
[15]
|
Cantley, L.C. (2002) The Phosphoinositide 3-Kinase Pathway. Science, 296, 1655-1657.
https://doi.org/10.1126/science.296.5573.1655
|
[16]
|
余跃伟, 夏春. 软骨细胞凋亡与PI3K/Akt途径及相关信号分子的研究进展[J]. 临床骨科杂志, 2009, 12(4): 457-460.
|
[17]
|
Zhang, Y.C., Cheng, T. and Yuan, W.P. (2013) Re-cent Studies on PI3K/AKT/mTOR Signaling Pathway in Hematopoietic Stem Cells. Journal of Experimental Hematology, 21, 245-249.
|
[18]
|
孙正平, 梁灿德, 吴少鹏, 等. 补肾活血方对人成骨细胞的增殖和分化中p38MAPK及P13K/Akt信号转导通路的影响[J]. 世界中西医结合杂志, 2015, 10(11): 1589-1592.
|
[19]
|
陈小香, 邓伟民, 魏秋实, 等. 从GH/IGF-1轴与P13K/Akt通路探讨老年骨质疏松症的发病机制[J]. 中国骨质疏松杂志, 2015, 21(11): 1412-1415.
|
[20]
|
江春燕, 宋成文. P13K/AKT信号通路对骨髓间充质干细胞行为学调节的研究进展[J]. 湖南中医杂志, 2017, 33(12): 176-178.
|
[21]
|
Ulici, V., Hoenselaar, K.D., Agoston, H., et al. (2009) The Role of Akt 1 in Teminal Stages of Endochondral Bone Fonnation: Angiogenesis and Ossification. Bone, 45, 1133-1145. https://doi.org/10.1016/j.bone.2009.08.003
|
[22]
|
Gu, Y.X., Du, J., Si, M.S., et al. (2013) The Roles of PI3K/Akt Signaling Pathway in Regulating MC3T3-E1 Preosteoblast Proliferation and Differentiation on SLA and SLActive Tita-nium Surfaces. Journal of Biomedical Materials Research, 101, 748-754. https://doi.org/10.1002/jbm.a.34377
|
[23]
|
Lee, S.U., Shin, H.K. and Min, Y.K. (2008) Emodin Accelerates Osteo-blast Differentiation through Phosphatidylinositol 3-Kinase Activation and Bone Morphogenetic Protein-2 Gene Expres-sion. International Immunopharmacology, 8, 741-747. https://doi.org/10.1016/j.intimp.2008.01.027
|
[24]
|
Chen, L.L., Huang, M., Tan, J.Y., et al. (2013) PI3K/AKT Pathway Involvement in the Osteogenic Effects of Osteoclast Cul-ture Supernatants on Preosteoblast Cells. Tissue Engineering Part A, 19, 2226-2232.
https://doi.org/10.1089/ten.tea.2012.0469
|
[25]
|
Adapala, N.S., Barbe, M.F., Tsygankov, A.Y., et al. (2014) Loss of Cbl-PI3K Interaction Enhances Osteoclast Survival Due to p21-Ras Mediated PI3K Activation Independent of Cbl-b. Journal of Cellular Biochemistry, 115, 1277-1289.
https://doi.org/10.1002/jcb.24779
|
[26]
|
Park, S.J., Kim, S.H., Choi, H.S., et al. (2009) Fibroblast Growth Factor 2-Induced Cytoplasmic Asparaginyl-tRNA Synthetase Promotes Survival of Osteoblasts by Regulating Anti-Apoptotic P13K/Akt Signaling. Bone, 45, 994-1003.
https://doi.org/10.1016/j.bone.2009.07.018
|
[27]
|
Dufour, C., Holy, X. and Marie, P.J. (2008) Transforming Growth Factor Beta Prevents Osteoblast Apoptosis Induced by Skeletal Unloading via P13K/Akt, Bcl.2, and Phosphor Bad Sig-naling. American Journal of Physiology-Endocrinology and Metabolism, 294, 794-801. https://doi.org/10.1152/ajpendo.00791.2007
|
[28]
|
Wu, J.B., Fong, Y.C., Tsai, H.Y., et al. (2008) Naringin Induced Bone Morphogenetic Protein-2 Expression via P13K, Akt, c-Fos/c-Jun and AP.1 Pathway in Osteoblasts. European Journal of Pharmacology, 588, 333-341.
https://doi.org/10.1016/j.ejphar.2008.04.030
|
[29]
|
Fukuda, A., Hikita, A., Wakeyama, H., et al. (2005) Regulation of Osteoclast Apoptosis and Motility by Small GTPase Binding Protein Rac1. Journal of Bone and Mineral Research, 20, 2245-2253. https://doi.org/10.1359/JBMR.050816
|
[30]
|
Moon, J.B., Kim, J.H., Kim, K., et al. (2012) Akt Induces Osteoclast Differentiation through Regulating the GSK313/NFATc1 Signaling Cascade. The Journal of Immunology, 188, 163-169.
https://doi.org/10.4049/jimmunol.1101254
|
[31]
|
Huang, L., Wang, Y., Jiang, Y., et al. (2018) High Levels of GSK-3β Signalling Reduce Osteogenic Differentiation of Stem Cells in Osteonecrosis of Femoral Head. The Journal of Biochemistry, 163, 243-251.
https://doi.org/10.1093/jb/mvx076
|
[32]
|
王雪鹏, 李茂强, 边振宇, 等. PI3K/Akt信号通路在骨髓间充质干细胞增殖及成骨分化调控中的作用[J]. 中华骨质疏松和骨矿盐疾病杂志, 2014(3): 250-257.
|
[33]
|
Lee, J.H., Kim, B.G., Ahn, J.M., et al. (2010) Role of PI3K on the Regulation of BMP2-Induced beta-Catenin Activation in Human Bone Marrow Stem Cells. Bone, 46, 1522-1532. https://doi.org/10.1016/j.bone.2010.02.013
|
[34]
|
Ford-Hutchinson, A.F., Ali, Z., Lines, S.E., et al. (2007) Inactivation of Pten in Osteochondroprogenitor Cells Leads to Epiphyseal Growth Plate Abnormalities and Skeletal Overgrowth. Journal of Bone and Mineral Research, 22, 1245-1259.
https://doi.org/10.1359/jbmr.070420
|
[35]
|
Liu, X., Bruxvoort, K.J., Zylstra, C.R., et al. (2007) Lifelong Accumula-tion of Bone in Mice Lacking Pten in Osteoblasts. Proceedings of the National Academy of Sciences of the United States of America, 104, 2259-2264.
https://doi.org/10.1073/pnas.0604153104
|
[36]
|
于世凤. 破骨细胞及其骨吸收调控研究进展[J]. 中国骨质疏松杂志, 2000, 6(1): 78-83.
|
[37]
|
Miron, R.J. and Bosshardt, D.D. (2016) OsteoMacs: Keyplayers around Bone Bio-materials. Biomaterials, 82, 1-19.
https://doi.org/10.1016/j.biomaterials.2015.12.017
|
[38]
|
Fujii, T., et al. (2012) IL-4 Inhibits TNF-α-Mediatedosteoclast Formation by Inhibition of RANKL Expression in TNF-α-Activated Stromal Cells and Direct Inhibition of TNF-α-Activated Osteoclast Precursors via a T-Cell-Independent Mechanism in Vivo. Bone, 51, 771-780. https://doi.org/10.1016/j.bone.2012.06.024
|
[39]
|
Neale, S.D., Smith, R., Wass, J.A., et al. (2000) Osteoclast Dif-ferentiation from Circulating Mononuclear Precursors in Paget’s Disease Is Hypersensitive to 1,25-Dihydroxyvitamin D 3 and RANKL. Bone, 27, 409-416.
https://doi.org/10.1016/S8756-3282(00)00345-8
|
[40]
|
Hwang, Y.S., Ma, G.T., Park, K.K., et al. (2014) Lyso-phosphatidic Acid Stimulates Osteoclast Fusion through OC-STAMP and P2X7 Receptor Signaling. Journal of Bone and Mineral Metabolism, 32, 110-122.
https://doi.org/10.1007/s00774-013-0470-9
|
[41]
|
Tsubaki, M., Komai, M., Itoh, T., et al. (2014) Nitro-gen-Containing Bisphosphonates Inhibit RANKL- and M-CSF-Induced Osteoclast Formation through the Inhibition of ERK1/2 and Akt Activation. Journal of Biomedical Science, 21, 10. https://doi.org/10.1186/1423-0127-21-10
|
[42]
|
Muruganandan, S. and Sinal, C.J. (2014) The Impact of Bone Mar-row Adipocytes on Osteoblast and Osteoclast Differentiation. IUBMB Life, 66, 147-155. https://doi.org/10.1002/iub.1254
|
[43]
|
杨一秋, 李兰, 赵娜, 等. PI3K/AKT信号通路与骨质疏松关系的研究进展[J]. 中国老年学杂志, 2022, 42(24): 6144-6148.
|
[44]
|
Liu, K., Yang, Y., Zhou, F., et al. (2020) Inhibition of PI3K/AKT/mTOR Signaling Pathway Promotes Autophagy and Relieves Hyperalgesia in Diabetic Rats. NeuroReport, 31, 644-649. https://doi.org/10.1097/WNR.0000000000001461
|
[45]
|
Pala, E. and Denkçeken, T. (2019) Differen-tially Expressed Circulating miRNAs in Postmenopausal Osteoporosis: A Meta-Analysis. Bioscience Reports, 39, 667-675. https://doi.org/10.1042/BSR20190667
|
[46]
|
张莹, 周艳红, 李江雁, 等. 基于PI3K/Akt通路研究利拉鲁肽对2型糖尿病骨质疏松大鼠的作用[J]. 中国骨质疏松杂志, 2021(7): 985-989.
|
[47]
|
Chanda, D., Kumar, S. and Ponnazhagan, S. (2010) Therapeutic Potential of Adult Bone Marrow-Derived Mesenchymal Stem Cells in Diseases of the Skeleton. Journal of Cellular Biochemistry, 111, 249-257.
https://doi.org/10.1002/jcb.22701
|
[48]
|
史东梅, 董明, 陆颖, 等. PI3K/Akt信号通路与骨破坏: 问题与机制[J]. 中国组织过程研究, 2020, 24(23): 3716-3722.
|